Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ixazomib is indicated for the treatment of multiple myeloma. Its mechanism of ac···【more】
Release date：2026-01-07Recommended：96
Ixazomib is a medication indicated for the treatment of multiple myeloma, exerti···【more】
Release date：2026-01-07Recommended：103
Ixazomib is indicated for the treatment of multiple myeloma, a type of bone marr···【more】
Release date：2026-01-07Recommended：92
Ixazomib is a second-generation proteasome inhibitor that has emerged as a pivot···【more】
Release date：2026-01-07Recommended：87
Ixazomib is a targeted, reversible proteasome inhibitor that has been approved f···【more】
Release date：2026-01-07Recommended：113
Ixazomib is part of an all-oral treatment regimen. When used in combination with···【more】
Release date：2026-01-07Recommended：132
On September 9, 2015, Cambridge, Massachusetts, USA, and Osaka, Japan, announced···【more】
Release date：2026-01-07Recommended：91
The U.S. Food and Drug Administration (FDA) approved ixazomib today for use in c···【more】
Release date：2026-01-07Recommended：96
Ivosidenib is available only with a doctor's prescription.Important Precauti···【more】
Release date：2026-01-07Recommended：172
KRAS G12C mutation in non-small cell lung cancer and colorectal cancer【more】
Release date：2026-01-06Recommended：30
Larotrectinib is indicated for the treatment of adult and pediatric patients wit···【more】
Release date：2026-01-06Recommended：28
Non-small cell lung cancer【more】
Release date：2026-01-06Recommended：64
